The ACTA team
Acta joins Alzheimer’s research pioneers, commercial leaders, clinical development experts, and biotech executives with deep experience moving discoveries to patients.
Deep expertise. Shared purpose. Seasoned leadership.
Scientific founder & director
Harvard Medical School-Massachusetts General Hospital neuroscientist, co-discoverer of all three familial early-onset Alzheimer’s genes, and co-creator of Alzheimer’s-in-a-Dish™ .
Co-founder, CEO & director
Seasoned C-level executive and former investment banker with 40+ years of company-building experience and nearly $40B in capital formation and M&A transactions.
Chief operating officer
Clinical and regulatory leader with nearly 30 years advancing therapies from discovery through late-stage development, regulatory submission, manufacturing, and quality systems.
Chief scientific officer
GSM biology and rational drug design expert who advanced Acta’s lead GSM‑669T candidate from rational design through IND-enabling studies.
SVP of strategy
Biotech and health-tech executive with 40+ years in company formation, product development, commercialization, capital formation, and strategic transactions.
Vice president clinical operations
Clinical operations leader with 25+ years delivering early-phase trials across pharma, biotech, government, and academia, with focus in neurology and special populations.
Scientific advisors
AdvisorMorris Distinguished ProfessorDept. of NeurologyWashington University School of Medicine
AdvisorDistinguished Professor of NeurosciencesUC San Diego School of Medicine
AdvisorReynolds Family Professor of Neuroscience University of Chicago